| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1730 |
| Trial ID | NCT03155191 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TBI1501 |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia |
| Year | 2017 |
| Country | Japan |
| Company sponsor | Takara Bio Inc. |
| Other ID(s) | 1501-01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||